Literature DB >> 22553261

What to do when a smoker's CT scan is "normal"?: Implications for lung cancer screening.

Joanna H Zurawska1, Rachel Jen1, Stephen Lam2, Harvey O Coxson3, Jonathon Leipsic4, Don D Sin5.   

Abstract

Lung cancer is the leading cause of cancer-related mortality in the United States and around the world. There are > 90 million current and ex-smokers in the United States who are at increased risk of lung cancer. The published data from the National Lung Screening Trial (NLST) suggest that yearly screening with low-dose thoracic CT scan in heavy smokers can reduce lung cancer mortality by 20% and all-cause mortality by 7%. However, to implement this program nationwide using the NLST inclusion and exclusion criteria would be extremely expensive, with CT scan costs alone > $2 billion per annum. In this article, we offer a possible low-cost strategy to risk-stratify smokers on the basis of spirometry measurements and emphysema scoring by radiologists on CT scans.

Entities:  

Mesh:

Year:  2012        PMID: 22553261      PMCID: PMC3415147          DOI: 10.1378/chest.11-1863

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  23 in total

1.  A risk model for prediction of lung cancer.

Authors:  Margaret R Spitz; Waun Ki Hong; Christopher I Amos; Xifeng Wu; Matthew B Schabath; Qiong Dong; Sanjay Shete; Carol J Etzel
Journal:  J Natl Cancer Inst       Date:  2007-05-02       Impact factor: 13.506

2.  Fleischner Society: glossary of terms for thoracic imaging.

Authors:  David M Hansell; Alexander A Bankier; Heber MacMahon; Theresa C McLoud; Nestor L Müller; Jacques Remy
Journal:  Radiology       Date:  2008-01-14       Impact factor: 11.105

Review 3.  Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis.

Authors:  S Wasswa-Kintu; W Q Gan; S F P Man; P D Pare; D D Sin
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

Review 4.  Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease.

Authors:  Ann G Schwartz; John C Ruckdeschel
Journal:  Am J Respir Crit Care Med       Date:  2005-09-01       Impact factor: 21.405

5.  The TERT-CLPTM1L locus for lung cancer predisposes to bronchial obstruction and emphysema.

Authors:  E Wauters; D Smeets; J Coolen; J Verschakelen; P De Leyn; M Decramer; J Vansteenkiste; W Janssens; D Lambrechts
Journal:  Eur Respir J       Date:  2011-05-26       Impact factor: 16.671

6.  Variations in lung cancer risk among smokers.

Authors:  Peter B Bach; Michael W Kattan; Mark D Thornquist; Mark G Kris; Ramsey C Tate; Matt J Barnett; Lillian J Hsieh; Colin B Begg
Journal:  J Natl Cancer Inst       Date:  2003-03-19       Impact factor: 13.506

Review 7.  Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

Authors:  Anthony J Alberg; Jean G Ford; Jonathan M Samet
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

8.  Association of radiographic emphysema and airflow obstruction with lung cancer.

Authors:  David O Wilson; Joel L Weissfeld; Arzu Balkan; Jeffrey G Schragin; Carl R Fuhrman; Stephen N Fisher; Jonathan Wilson; Joseph K Leader; Jill M Siegfried; Steven D Shapiro; Frank C Sciurba
Journal:  Am J Respir Crit Care Med       Date:  2008-06-19       Impact factor: 21.405

Review 9.  The International Epidemiology of Lung Cancer: geographical distribution and secular trends.

Authors:  Danny R Youlden; Susanna M Cramb; Peter D Baade
Journal:  J Thorac Oncol       Date:  2008-08       Impact factor: 15.609

10.  Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest.

Authors:  Juan P de Torres; Gorka Bastarrika; Juan P Wisnivesky; Ana B Alcaide; Arantza Campo; Luis M Seijo; Jesús C Pueyo; Alberto Villanueva; María D Lozano; Usua Montes; Luis Montuenga; Javier J Zulueta
Journal:  Chest       Date:  2007-12       Impact factor: 9.410

View more
  6 in total

Review 1.  Epidemic of lung cancer in patients with HIV infection.

Authors:  Tiffany A Winstone; S F Paul Man; Mark Hull; Julio S Montaner; Don D Sin
Journal:  Chest       Date:  2013-02-01       Impact factor: 9.410

Review 2.  Chronic obstructive pulmonary disease as a risk factor for lung cancer.

Authors:  Yuichi Takiguchi; Ikuo Sekine; Shunichiro Iwasawa; Ryota Kurimoto; Koichiro Tatsumi
Journal:  World J Clin Oncol       Date:  2014-10-10

3.  Is generalization of exhaled CO assessment in primary care helpful for early diagnosis of COPD?

Authors:  Nicolas Molinari; Mathieu Abou-Badra; Grégory Marin; Chin-Long Ky; Noemi Amador; Anne Sophie Gamez; Isabelle Vachier; Arnaud Bourdin
Journal:  BMC Pulm Med       Date:  2015-04-28       Impact factor: 3.317

4.  The impact of emphysema on dosimetric parameters for stereotactic body radiotherapy of the lung.

Authors:  Satoru Ochiai; Yoshihito Nomoto; Yasufumi Yamashita; Tomoki Inoue; Shuuichi Murashima; Daisuke Hasegawa; Yoshie Kurita; Yui Watanabe; Yutaka Toyomasu; Tomoko Kawamura; Akinori Takada; Shigeki Kobayashi; Hajime Sakuma
Journal:  J Radiat Res       Date:  2016-07-05       Impact factor: 2.724

5.  Estimation of lung cancer risk using homology-based emphysema quantification in patients with lung nodules.

Authors:  Mizuho Nishio; Takeshi Kubo; Kaori Togashi
Journal:  PLoS One       Date:  2019-01-22       Impact factor: 3.240

Review 6.  [Research Progress on Lung Cancer Screening].

Authors:  Yazhe Guan; Meng Ren; Dongli Guo; Yutong He
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-08-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.